Tetroxoprim → HCID 54252433, 화합물
반응식
[CH3:1][O:2][CH2:3][CH2:4][O:5][C:6]1[C:7]([O:23][CH3:24])=[CH:8][C:9]([CH2:14][C:15]2[CH:16]=[N:17][C:18]([NH2:22])=[N:19][C:20]=2[NH2:21])=[CH:10][C:11]=1[O:12][CH3:13].C[O:26]C1C=C(C=C(OC)C=1OCCOC)C=O.NC1N=C(N)C=C(O)N=1>>[NH2:22][C:18]1[N:19]=[C:20]([NH2:21])[C:15](=[CH:14][C:9]2[CH:10]=[C:11]([O:12][CH3:13])[C:6]([O:5][CH2:4][CH2:3][O:2][CH3:1])=[C:7]([O:23][CH3:24])[CH:8]=2)[C:16](=[O:26])[N:17]=1참가 물질
4
실험 절차
A process for preparing Tetroxoprim starting from 3,5-dimethoxy-4-methoxyethoxy-benzaldehyde and 2,4-diamino-6-hydroxy-pyrimidine, by successive hydrogenation, halogenation and hydrogenolysis of the 2,4-diamino-6-oxo-5-(3,5-dimethoxy-4-methoxyethoxy-benzylidene)-pyrimidine obtained in the initial reaction.
출처 및 근거
- ORD 기록
- ord-0fbcdc313ee04c868d1705a2902abe9c
- 출처 데이터셋
- uspto-grants-1984_11